Target the human Alanine/Serine/Cysteine Transporter 2(ASCT2): Achievement and Future for Novel Cancer Therapy

Hongli Jiang1, Ning Zhang1, Tongzhong Tang1

  • 1Department of Natural Medicinal Chemistry, China Pharmaceutical University, Nanjing 210009, China.

Insights

Alanine-Serine-Cysteine Transporter 2 (ASCT2) is crucial for cancer cell growth. Inhibiting ASCT2 offers a promising strategy for developing new cancer therapies.

Area of Science:

  • Cellular metabolism
  • Cancer biology
  • Drug discovery

Background:

  • Glutamine metabolism is vital for cell growth, providing energy and building blocks.
  • Alanine-Serine-Cysteine Transporter 2 (ASCT2), encoded by SLC1A5, is a key transporter for glutamine uptake.
  • ASCT2 is frequently overexpressed in cancer cells to meet their high glutamine demands.

Purpose of the Study:

  • To review the structure and regulatory factors of ASCT2.
  • To highlight the development of ASCT2 inhibitors for cancer therapy.
  • To discuss future perspectives on targeting ASCT2.

Main Methods:

  • Literature review of ASCT2 structure and function.
  • Analysis of regulatory factors impacting ASCT2.
  • Summary of ASCT2 inhibitor discovery and development.

Main Results:

  • ASCT2 plays a significant role in cancer cell proliferation.
  • ASCT2 inhibitors show potential as a therapeutic strategy.
  • Regulatory factors associated with ASCT2 influence antitumor activity.

Conclusions:

  • ASCT2 is a validated target in cancer therapy.
  • Further research into ASCT2 inhibitors is warranted.
  • Targeting ASCT2 presents a promising avenue for novel cancer treatments.

Related Concept Videos

ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
6.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
888
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Active Transport01:14

Active Transport

Active transport is a critical biological process that allows cells to move solutes against an electrochemical gradient. This process requires direct energy input and is characterized by its selectivity, saturability, and susceptibility to competitive inhibition.
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
1.8K